ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Telesis Bio Inc

Telesis Bio Inc (TBIO)

1.81
0.00
(0.00%)
Closed September 13 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.81
Bid
1.62
Ask
1.79
Volume
-
0.00 Day's Range 0.00
1.45 52 Week Range 677.52
Market Cap
Previous Close
1.81
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
112,600
Shares Outstanding
1,772,946
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-27.65
Revenue
27.51M
Net Profit
-49.02M

About Telesis Bio Inc

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Headquarters
Wilmington, Delaware, USA
Founded
-
Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was $1.81. Over the last year, Telesis Bio shares have traded in a share price range of $ 1.45 to $ 677.52.

Telesis Bio currently has 1,772,946 shares outstanding. The market capitalization of Telesis Bio is $3.21 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.07.

TBIO Latest News

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate...

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.79-49.72222222223.64.07991.45651382.54352021CS
4-1.73-48.87005649723.546.061.451342994.20369776CS
12-8.27-82.043650793710.0810.4221.451126005.08134345CS
26-19.97-91.689623507821.7824.481.453015479.25396437CS
52-671.75-99.7312785795673.56677.521.4522852024.14032671CS
156-185.39-99.0331196581187.2683.731.45732789360.17008277CS
2600004.0799000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.133
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.3698
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.77
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5108
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.133
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.3698
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.77
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5108
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.133
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.3698
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.77
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5108
(0.00%)
0

TBIO Discussion

View Posts
Awl416 Awl416 2 days ago
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
👍️0
Awl416 Awl416 1 month ago
What’s the deal with this sucker
👍️0
Awl416 Awl416 1 month ago
Lol
👍️0
Awl416 Awl416 1 month ago
Don’t blink
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
somebody is getting smoked here
👍️0
tw0122 tw0122 2 months ago
5.50s
👍️0
observer21 observer21 3 months ago
Anyone have a clue as to why the jump today?
👍️0
TOM611 TOM611 7 months ago
Go. TBiO. Life. Enhancing. Patent
👍️0
Hikiro Hikiro 7 months ago
I personally see this consolidating Monday between .55 and .45
👍️0
glenn1919 glenn1919 7 months ago
TBIO...............................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
👍️0
XenaLives XenaLives 7 months ago
This one scares the crap out of me...

Imagine replication of COVID ( or the next worst thing) with out a biological matrix.

December 5, 2023 | LIVE WEBINAR
Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development
Immuno-oncology is a rapidly growing area for therapeutic development. With the adoption of various autologous cell therapies and an increased focus on more broadly applicable allogeneic treatments and multi-specific therapies, the complexity of these development activities is also increasing. With this drive to increased complexity and the inherent risks associated with potential failure in Phase 1 clinical trials, it is critical to have a solid scientific foundation for the development of these next-generation immunotherapies. This talk will focus on how to overcome the limitations associated with traditional viral vector based recombinant TCR gene expression to build hundreds of candidates a week, resulting in improved confidence in screening and lead optimization. With the direct use of mRNA to drive transient modulation of cellular phenotypes, potential candidates can be screened quickly and cost-effectively. Come and learn how immuno-oncology researchers are automating synthetic biolological...



$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
👍️0
TOM611 TOM611 7 months ago
Wow, a patent to clone that’s incredible
👍️0
observer21 observer21 7 months ago
Gosh. Such wisdom. Thanks for enlightening us with that critical information.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
dilutive bio stocks under 1.00 are like pink sheets on steroids...ya better know how to trade em or you will lose yo money fast!!!
👍️0
Invest-in-America Invest-in-America 7 months ago
TBIO: Right here in my San Diego --- grab some?????
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
Chart plays are never tricky. Stick to bullish stocks. Day trading pop and drops, ya better have skills and understand intraday 60 min charting, order flow and how to spot the shorts.
👍️0
TimeFades TimeFades 7 months ago
Tricky day
👍️0
Awl416 Awl416 7 months ago
New highs AH
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
LETS JUST SAY MOST AH POPS ARE DILUTION, ESPECIALLY THE BIO SPACE.
👍️0
TheFinalCD TheFinalCD 7 months ago
THX
👍️0
TimeFades TimeFades 7 months ago
Another short opp
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
AFTER HOUR DILUTION TAKING PLACE...CHASE AND CRY PLAY!
👍️0
Awl416 Awl416 7 months ago
What leaked?
👍️0
Zorro Zorro 7 months ago
Nice one!
👍️0
Invest-in-America Invest-in-America 7 months ago
TBIO: VIBRIO NATRIEGENS (So, what's NEW, Pussycat??!!)

👍️0
TheFinalCD TheFinalCD 7 months ago
$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
👍️0
observer21 observer21 8 months ago
Anyone know why the huge jump in price and volume?
👍️0

Your Recent History

Delayed Upgrade Clock